Skip to main content
Clinical Trials/ACTRN12610001029088
ACTRN12610001029088Not yet recruitingPhase 2

A feasibility study for a randomized controlled trial of Gastrografin in the management of malignant bowel obstruction

Ian Bissett0 sites20 target enrollmentStarted: November 23, 2010Last updated:
Conditions

Trial Snapshot

Phase
Phase 2
Status
Not yet recruiting
Sponsor
Enrollment
20

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • Inclusion Criteria
  • -Age >18 years
  • -Satisfy criteria for a MBO
  • -No indication for immediate surgery
  • -Able to understand the risks/benefits of the study
  • -Able to give informed written consent
  • -Any further treatment (surgery, chemotherapy,
  • radiotherapy, hormone therapy, biological/targeted
  • therapies) is deemed by relevant practitioners unlikely
  • to change the acute management of the bowel
  • obstruction.

Exclusion Criteria

  • Exclusion Criteria
  • -Known allergic reaction to study medication or
  • -Grossly distended stomach on radiologic exam
  • -Venting or feeding gastrostomy or jejunostomy
  • -Pregnancy

Investigators

Sponsor
Ian Bissett

Similar Trials